pyrroles has been researched along with Contact Dermatitis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Igarashi, A; Kaino, H; Murata, R; Nagata, T; Nakagawa, H; Nemoto, O; Saeki, H | 1 |
Cho, S; Lee, JS; Park, HS; Yoon, HS | 1 |
Gu, Y; Meng, F; Qu, B; Shu, Y; Sun, Y; Xu, Q; Zhao, W; Zhu, X | 1 |
1 trial(s) available for pyrroles and Contact Dermatitis
Article | Year |
---|---|
Long-term safety and efficacy of delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with atopic dermatitis.
Topics: Acne Vulgaris; Adolescent; Adult; Dermatitis, Atopic; Dermatitis, Contact; Drug Administration Schedule; Female; Folliculitis; Humans; Incidence; Janus Kinase Inhibitors; Japan; Male; Nasopharyngitis; Ointments; Pyrroles; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult | 2020 |
2 other study(ies) available for pyrroles and Contact Dermatitis
Article | Year |
---|---|
Therapeutic synergy between contact dermatitis from a wig-fixing device and tofacitinib on alopecia areata.
Topics: Adult; Alopecia Areata; Dermatitis, Contact; Hair; Humans; Male; Piperidines; Pyrimidines; Pyrroles; Silicone Gels; Treatment Outcome | 2019 |
Sunitinib impairs the proliferation and function of human peripheral T cell and prevents T-cell-mediated immune response in mice.
Topics: Aged; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Cycle; Cytokines; Dermatitis, Contact; Female; Flow Cytometry; Histocytochemistry; Humans; Indoles; Lymphocyte Activation; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Middle Aged; Neoplasms; Picryl Chloride; Pyrroles; Specific Pathogen-Free Organisms; Sunitinib; T-Lymphocytes | 2010 |